These once-weekly injectable peptide medications are key elements in known FDA-approved brands that treat diabetes, obesity and excess weight
According to NICE guideline NG12, postmenopausal bleedingany vaginal bleeding occurring more than twelve months after the last menstrual periodalways requires urgent investigation with referral via the suspected cancer pathway (within 2 weeks), regardless of medication use, as it may indicate endometrial pathology
(Some NASH trials look at these endpoints in the reverse order.) More participants taking any dose of semaglutide experienced NASH resolution (40%, 36% and 59%, respectively, in the 0.1, 0.2, and 0.4 mg dose groups) compared with the placebo arm (17%)
Footnotes *These authors contributed equally to this study
While its not a standalone addiction treatment, it can complement recovery plans, giving patients an extra tool to manage urges and avoid relapse